{"id": "1385982748683243525", "creation": 1619279012.0, "user_id": "1321134820894846976", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "Ocugen #NASDAQ: $OCGN, its partner, Bharat #Biotech, released data from its Phase 3 trial of #COVID19 #vaccine, Covaxin. The vaccine had efficacy in mild &amp; moderate COVID-19 disease of 78% with efficacy against severe COVID-19 disease of 100%. It closed the week up 67% to $9.63. https://t.co/SlkKy8gXNS", "first_save": 1634559108.199414, "hashtags": ["#NASDAQ", "#BIOTECH", "#COVID19", "#VACCINE"]}